Isola J - Search Results

1

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.

Laakso M, Loman N, Borg A, Isola J. Laakso M, et al. Among authors: isola j. Mod Pathol. 2005 Oct;18(10):1321-8. doi: 10.1038/modpathol.3800456. Mod Pathol. 2005. PMID: 15990899

2

Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.

Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J. Visakorpi T, et al. Among authors: isola j. J Natl Cancer Inst. 1992 Jun 3;84(11):883-7. doi: 10.1093/jnci/84.11.883. J Natl Cancer Inst. 1992. PMID: 1350643

3

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.

Toikkanen S, Helin H, Isola J, Joensuu H. Toikkanen S, et al. Among authors: isola j. J Clin Oncol. 1992 Jul;10(7):1044-8. doi: 10.1200/JCO.1992.10.7.1044. J Clin Oncol. 1992. PMID: 1351537

4

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Isola J, Visakorpi T, Holli K, Kallioniemi OP. Isola J, et al. J Natl Cancer Inst. 1992 Jul 15;84(14):1109-14. doi: 10.1093/jnci/84.14.1109. J Natl Cancer Inst. 1992. PMID: 1352359

5

Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.

Visakorpi T, Kallioniemi OP, Koivula T, Harvey J, Isola J. Visakorpi T, et al. Among authors: isola j. Mod Pathol. 1992 Nov;5(6):643-8. Mod Pathol. 1992. PMID: 1369801

6

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Kallioniemi OP, et al. Among authors: isola jj. Int J Cancer. 1991 Nov 11;49(5):650-5. doi: 10.1002/ijc.2910490504. Int J Cancer. 1991. PMID: 1682277

7

Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.

Isola J, Kallioniemi OP, Korte JM, Wahlström T, Aine R, Helle M, Helin H. Isola J, et al. J Pathol. 1990 Dec;162(4):295-301. doi: 10.1002/path.1711620404. J Pathol. 1990. PMID: 2290114

8

Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.

Isola JJ, Helin HJ, Helle MJ, Kallioniemi OP. Isola JJ, et al. Cancer. 1990 Mar 1;65(5):1180-4. doi: 10.1002/1097-0142(19900301)65:5<1180::aid-cncr2820650525>3.0.co;2-7. Cancer. 1990. PMID: 2406010

9

Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.

Helin HJ, Helle MJ, Helin ML, Isola JJ. Helin HJ, et al. Among authors: isola jj. Am J Clin Pathol. 1988 Aug;90(2):137-42. doi: 10.1093/ajcp/90.2.137. Am J Clin Pathol. 1988. PMID: 2456008

10

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.

Helin HJ, Helle MJ, Kallioniemi OP, Isola JJ. Helin HJ, et al. Among authors: isola jj. Cancer. 1989 May 1;63(9):1761-7. doi: 10.1002/1097-0142(19900501)63:9<1761::aid-cncr2820630918>3.0.co;2-3. Cancer. 1989. PMID: 2649227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results